-
Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results
Post on 2/17/21
-
Citybiz Interview with Jim Rogers, CEO HealthConnect Networks and Mission Broadband
Post on 2/19/21
-
Elicio Therapeutics Secures $73 Million in Series B
Post on 2/17/21
-
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results
Post on 2/17/21
-
ImmuneID Launches with $17M Financing
Post on 2/17/21
-
Charles River Laboratories to Acquire Cognate BioServices for $875 Million
Post on 2/17/21
-
Moderna Hits a Short-Term Vaccine Manufacturing Delay, Still on Track for First 100 Million Doses by End of March
Post on 2/17/21
-
KalVista Pharmaceuticals Closes its Upsized Public Offering of Common Stock
Post on 2/16/21
-
Pulmatrix Closes of $40 Million Registered Direct Offering
Post on 2/16/21
-
CVS Health Reports Fourth Quarter And Full-Year 2020 Results
Post on 2/16/21
-
IQVIA Offers of Senior Notes
Post on 2/16/21
-
Centessa Pharmaceuticals Launches with $250 Million Series A Financing
Post on 2/16/21
-
The CM Group Acquires Scientific Commercialization
Post on 2/16/21
-
Baudax Bio Reports 2020 Annual Financial Results
Post on 2/16/21
-
Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna
Post on 2/16/21
-
Road to Responsibility Holds Vaccine Clinics for Staff and Residents
Post on 2/13/21
-
Radius Health Provides Abaloparatide Business Update
Post on 2/12/21
-
Infinity Prices of $80 Million Public Offering of Common Stock
Post on 2/12/21
-
SQZ Biotech Prices of Public Offering of Common Stock
Post on 2/12/21
-
Conformis Prices of $85 Million Underwritten Offering of Common Stock
Post on 2/12/21
-
Arch Therapeutics Announces $6.9 Million Private Placement
Post on 2/12/21
-
Forget Moderna! This Is a More Lucrative Coronavirus Stock
Post on 2/12/21
-
Codiak Prices of $57.8 Million Public Offering of Common Stock
Post on 2/12/21
-
Decibel Therapeutics Prices of IPO
Post on 2/12/21
-
Infinity Announces Proposed Public Offering of Common Stock
Post on 2/11/21